Annexon Advances Classical Complement Platform with Initiation of Global Phase 2 ARCHER Trial in Patients with Geographic AtrophyGlobeNewsWire • 03/01/21
Annexon Highlights Recent Achievements and Outlines Expected Key Milestones in 2021 for Its Broad Portfolio of Complement TherapeuticsGlobeNewsWire • 01/12/21